- Home
- IPHA vs KGEI Comparison
IPHA vs KGEI Comparison
Compare IPHA & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IPHA | KGEI |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 163.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | KGEI |
|---|---|---|
| Price | $1.96 | $4.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.00 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 565.0K | 76.1K |
| Earning Date | 09-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.99 |
| EPS | N/A | ★ 0.49 |
| Revenue | $14,839,695.00 | ★ $60,121,000.00 |
| Revenue This Year | $22.29 | $2.54 |
| Revenue Next Year | $43.90 | $12.86 |
| P/E Ratio | ★ N/A | $7.95 |
| Revenue Growth | N/A | ★ 10.00 |
| 52 Week Low | $1.43 | $3.71 |
| 52 Week High | $3.51 | $9.89 |
Technical Indicators
Market Signals| Indicator | IPHA | KGEI |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 42.04 |
| Support Level | $1.85 | $3.94 |
| Resistance Level | $2.01 | $4.11 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 69.64 | 56.25 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.